Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - June 4, 2023 Category: Cancer & Oncology Authors: Benjamin Koh Darren Jun Hao Tan Wen Hui Lim Jeffrey S L Wong Cheng Han Ng Kai En Chan Meng Wang Wei Peng Yong Yock Young Dan Louis Z Wang Nigel Tan Mark Muthiah Alfred Kow Nicholas L. Syn Daniel Q. Huang Thomas Yau Source Type: research
Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinoma
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - June 1, 2023 Category: Cancer & Oncology Authors: Xiangfei Yuan Yang Lu Yuanyuan Yang Wencong Tian Dongmei Fan Ruoqi Liu Xiaomin Lei Yafei Xia Lei Yang Shu Yan Dongsheng Xiong Source Type: research
Studying TIGIT activity against tumors through the generation of knockout mice
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 30, 2023 Category: Cancer & Oncology Authors: Ahmed Rishiq Reem Bsoul Ophir Pick Ofer Mandelboim Source Type: research
Eribulin mesylate exerts antitumor effects via CD103
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 28, 2023 Category: Cancer & Oncology Authors: Kazumasa Oya Yoshiyuki Nakamura Rei Watanabe Ryota Tanaka Yuki Ichimura Noriko Kubota Yutaka Matsumura Hideaki Tahara Naoko Okiyama Manabu Fujimoto Toshifumi Nomura Yasuhiro Fujisawa Source Type: research
Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 28, 2023 Category: Cancer & Oncology Authors: Wen-Fang Tang Xiao-Jun Fan Hua Bao Rui Fu Yi Liang Min Wu Chao Zhang Jian Su Yi-Long Wu Wen-Zhao Zhong Source Type: research
CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variants
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 27, 2023 Category: Cancer & Oncology Authors: Na Qiu Akshaya Srikanth Medhanie Mulaw Umesh Tharehalli Shanthiya Selvachandran Martin Wagner Thomas Seufferlein Katja Stifter Andr é Lechel Reinhold Schirmbeck Source Type: research
FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 26, 2023 Category: Cancer & Oncology Authors: Lu Lu Yi-Xin Jiang Xiao-Xia Liu Jin-Mei Jin Wen-Jie Gu Xin Luan Ying-Yun Guan Li-Jun Zhang Source Type: research
T-cell dysfunction in natural killer/T-cell lymphoma
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 24, 2023 Category: Cancer & Oncology Authors: Xiaoyan Feng Miaomiao Meng Hongwen Li Yuyang Gao Wenting Song Ruiqing Di Zhaoming Li Xudong Zhang Mingzhi Zhang Source Type: research
Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 23, 2023 Category: Cancer & Oncology Authors: Nabeel Kajihara Yoshino Tanaka Riko Takeuchi Takuto Kobayashi Masafumi Tanji Tsukasa Ataka Shiho Nakano Taisho Yamada Akinori Takaoka Yoshinori Hasegawa Ken-Ichiro Seino Haruka Wada Source Type: research
B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 16, 2023 Category: Cancer & Oncology Authors: Ichwaku Rastogi Douglas G. McNeel Source Type: research
Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 16, 2023 Category: Cancer & Oncology Authors: Oliver Kepp Laurence Zitvogel Guido Kroemer Source Type: research
M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 14, 2023 Category: Cancer & Oncology Authors: Naisheng Zheng Tingting Wang Qin Luo Yi Liu Junyao Yang Yunlan Zhou Guohua Xie Yanhui Ma Xiangliang Yuan Lisong Shen Source Type: research
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 12, 2023 Category: Cancer & Oncology Authors: David Dora Balazs Ligeti Tamas Kovacs Peter Revisnyei Gabriella Galffy Edit Dulka D ániel Krizsán Regina Kalcsevszki Zsolt Megyesfalvi Balazs Dome Glen J. Weiss Zoltan Lohinai Source Type: research
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 11, 2023 Category: Cancer & Oncology Authors: A Daban C Gonnin L Phan A Saldmann C Granier A Lillo-Lelouet C Le Beller J Pouchot l Weiss E Tartour E Fabre J Medioni S Oudard YA Vano MA Dragon-Durey A. Simonaggio Source Type: research
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - May 10, 2023 Category: Cancer & Oncology Authors: Azar Rezapour Daniel Rydbeck Fabian Byvald Viktor Tasselius Gustaf Danielsson Eva Angenete Ulf Yrlid Source Type: research
